The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial
Billings, Liana K., Agner, Bue F. Ross, Altuntas, Yuksel, Grøn, Randi, Halladin, Natalie, Klonoff, David C., Tentolouris, Nikolaos, Jódar, EstebanJournal:
Journal of Diabetes Science and Technology
DOI:
10.1177/1932296820906888
Date:
February, 2020
File:
PDF, 666 KB
2020